BNP Paribas Financial Markets
ABOS icon

BNP Paribas Financial Markets’s Acumen Pharmaceuticals ABOS Stock Holding History

BNP Paribas Financial Markets’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.85K Sell
1,208
-16
-1% -$41 ﹤0.01% 5379
2025
Q4 		$2.58K Hold
1,224
– – ﹤0.01% 5326
2025
Q3 		$2.09K Sell
1,224
-810
-40% -$1.12K ﹤0.01% 5166
2025
Q2 		$2.36K Sell
2,034
-1,133
-36% -$1.22K ﹤0.01% 5038
2025
Q1 		$3.48K Sell
3,167
-3,850
-55% -$5.5K ﹤0.01% 4911
2024
Q4 		$12.1K Buy
+7,017
New +$16.9K ﹤0.01% 4821

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BNP Paribas Financial Markets's ABOS Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Acumen Pharmaceuticals (ABOS) stake by 1.3% in Q1 2026, selling an estimated $41 and leaving 1,208 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #5379.

BNP Paribas Financial Markets first reported a position in ABOS in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.1K in Q4 2024. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • BNP Paribas Financial Markets held 1,208 shares of Acumen Pharmaceuticals worth $2.85K as of Q1 2026.
  • BNP Paribas Financial Markets sold 16 Acumen Pharmaceuticals shares in Q1 2026, an estimated $41.
  • Acumen Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5379 holding.
  • BNP Paribas Financial Markets first reported a position in Acumen Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Acumen Pharmaceuticals position peaked at $12.1K in Q4 2024.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.